CAPTRUST Financial Advisors’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

CAPTRUST Financial Advisors’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,080	Closed	-$6K	–	5381
2021 Q4	$6K	Sell	2,080 -2,025	-49%	-$6.82K	﹤0.01%	4031
2021 Q3	$15K	Sell	4,105 -232	-5%	-$875	﹤0.01%	3378
2021 Q2	$16K	Buy	4,337 +2,152	+98%	+$7.59K	﹤0.01%	3287
2021 Q1	$9K	Hold	2,185	–	–	﹤0.01%	3513
2020 Q4	$9K	Buy	2,185 +185	+9%	+$713	﹤0.01%	2642
2020 Q3	$8K	Hold	2,000	–	–	﹤0.01%	2395
2020 Q2	$9K	Buy	+2,000	New	+$8.99K	﹤0.01%	2235

Other funds holding BDSI

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

FCMT

Founders Capital Management (Texas) Houston, Texas $231M AUM 61.68% 1-Year Est. Return

CAPTRUST Financial Advisors's BDSI Position: Q1 2022 in Review

CAPTRUST Financial Advisors sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 2,080 shares — an estimated $6K sold.

CAPTRUST Financial Advisors first reported a position in BDSI in Q2 2020 and held it in 7 quarters. The position peaked at $16K in Q2 2021. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

CAPTRUST Financial Advisors reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
CAPTRUST Financial Advisors sold 2,080 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $6K.
CAPTRUST Financial Advisors first reported a position in BioDelivery Sciences International, Inc. in Q2 2020 and held it in 7 quarters.
CAPTRUST Financial Advisors's BioDelivery Sciences International, Inc. position peaked at $16K in Q2 2021.
2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2022, filed 16 May 2022.